Nvidia and Eli Lilly are teaming up on a $1 billion AI-powered lab to accelerate drug discovery, combining robotics, ...

Converge Bio, the AI platform for accelerated drug discovery and development, announced today $25 million in Series A funding, bringing its total raised to $30 million. The round was led by Bessemer ...

The firm is focused on helping pharma characterize response and resistance to their drugs, with the hope of getting a companion diagnostic approval.

In Darwinian terms, survival isn’t a matter of being the biggest, the fastest, or the strongest of the species, but instead ...

A life sciences and health laboratory in Ann Arbor, Michigan, will be closed, with 76 jobs ending as a result.

Labcorp , a global leader of innovative and comprehensive laboratory services, today announced the continued expansion of its molecular residual disease (MRD)i portfolio designed to help clinicians ...

AI drug discovery startup Converge Bio raised $25 million in a Series A led by Bessemer Venture Partners, with additional ...

The global life sciences and health care company did not explain why it is closing the facility. The post Labcorp is closing ...

The company said that the sale of its medical device testing business would allow it to focus on core areas of preclinical drug development and chemical testing.

The move adds Labcorp’s US biocompatibility, analytical testing, and preclinical research services to Namsa’s operations.

Consumers Now Have More Choices to Purchase the Visby Device Featuring 30-Minute, Lab-Quality ResultsSAN JOSE, Calif.--(BUSINESS WIRE)--Today, Visby Medical announced two new relationships that will ...

NAMSA, a global leader in medical device testing, clinical research, and regulatory consulting, is pleased to announce it has ...